PHORA: A Clinical Decision Support Tool for Patients with Pulmonary Arterial Hypertension
PHORA:肺动脉高压患者的临床决策支持工具
基本信息
- 批准号:10187768
- 负责人:
- 金额:$ 65.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-01 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAddressAlgorithmsBayesian NetworkBiomedical EngineeringCaringChronic DiseaseClinicalClinical Decision Support SystemsClinical TrialsClinical Trials DesignCommunicationCommunitiesComputer softwareConsensusDataData SetDatabasesDecision MakingDecision Support SystemsDevelopmentDiagnosisDiseaseDisease ManagementEarly DiagnosisEducationEquationEvolutionFeedbackFocus GroupsFoundationsFutureGenerationsGoalsHealthcareHeart failureIndividualIndustryIntentionInterventionInvestigational DrugsKnowledgeLifeLightMachine LearningMeta-AnalysisModelingMorbidity - disease rateMulticenter TrialsObservational StudyOutcomePatient riskPatient-Focused OutcomesPatientsPharmaceutical PreparationsPhysiciansPulmonary HypertensionPulmonary Vascular ResistancePulmonary vesselsQuality of lifeRare DiseasesRegistriesResourcesRiskRisk AssessmentStandardizationStatistical MethodsStructureSurrogate EndpointTestingTherapeuticTherapeutic InterventionTrainingTreatment EffectivenessUncertaintyValidationbaseclinical databaseclinical decision supportclinical encounterclinical predictorscohortcomputer human interactioncomputer programcomputer sciencecostcost effectivecost effectivenessdata managementdata miningeffective therapyhospital readmissionhypertension treatmentimprovedindividual patientindividualized medicineintervention costmedical specialtiesmortalitymultidisciplinarynovel therapeuticsoutcome predictionpredictive modelingprognosticprognostic toolprospectiveprototypepulmonary arterial hypertensionresponseshared decision makingsuccesssupport toolssurvival predictiontheoriestime usetoolusabilityuser centered designuser-friendlyvascular abnormality
项目摘要
ABSTRACT
This application seeks to develop a multi-platform clinical decision support system (CDSS) in pulmonary
arterial hypertension (PAH) for physicians, PHORA (Pulmonary Hypertension Outcomes Risk
Assessment), which can be used to: (a) guide therapeutic decisions and (b) optimize clinical trial design. We
will achieve this goal by utilizing clinical trial data from several large databases of completed trials in PAH, an
ongoing PAH registry (REVEAL), as well as observational sessions with physicians. The proposed aims co-
create the CDSS with a multi-disciplinary group of specialties including: biomedical engineering, advanced
PAH physicians, computer science (machine learning/data mining), human computer interaction, and allied
health care experts. Our intention is to engage all stakeholders to achieve consensus and thereby assure the
acceptance of PHORA into practice. Successful completion of this project will lay the foundation for a
prospective, multi-center trial in which PHORA will be evaluated with respect to long-term patient outcomes.
The ultimate aim is to disseminate this resource so as to improve the efficiency, efficacy, and cost-
effectiveness of this treatment for PAH.
摘要
本申请旨在开发一个多平台的临床决策支持系统(CDSS),
医生动脉高血压(PAH),PHORA(肺动脉高血压结局风险
评估),可用于:(a)指导治疗决策和(B)优化临床试验设计。我们
将通过利用来自PAH已完成试验的几个大型数据库的临床试验数据来实现这一目标,
正在进行的PAH登记研究(REVEAL),以及与医生的观察性会议。建议的目标是:
创建CDSS与专业的多学科组,包括:生物医学工程,先进的
PAH医师、计算机科学(机器学习/数据挖掘)、人机交互及相关
卫生保健专家。我们的意图是让所有利益攸关方参与进来,以达成共识,从而确保
将PHORA付诸实践。该项目的成功完成将为
一项前瞻性、多中心试验,将评价PHORA对患者长期结局的影响。
最终目的是传播这一资源,以提高效率、效益和成本-
这种治疗对PAH的有效性。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Maternal and fetal outcomes in pregnant women with pulmonary hypertension: The impact of left heart disease.
肺动脉高压孕妇的母婴结局:左心疾病的影响。
- DOI:10.1016/j.ijcchd.2022.100354
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Marshall,WilliamH;Gee,Stephen;Lim,Woobeen;Lastinger,LaurenT;Cackovic,Michael;Benza,RaymondL;Daniels,CurtJ;Bradley,ElisaA;Rajpal,Saurabh
- 通讯作者:Rajpal,Saurabh
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RAYMOND Louis Benza其他文献
RAYMOND Louis Benza的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RAYMOND Louis Benza', 18)}}的其他基金
PHORA-Pulmonary Hypertension Outcome Risk Assessment
PHORA-肺动脉高压结果风险评估
- 批准号:
10990081 - 财政年份:2024
- 资助金额:
$ 65.64万 - 项目类别:
The Development of a Biatrial Catheter for a Cardiopulmonary Support System in Pulmonary Arterial Hypertension
肺动脉高压心肺支持系统双心导管的研制
- 批准号:
10669968 - 财政年份:2023
- 资助金额:
$ 65.64万 - 项目类别:
PHORA: A Clinical Decision Support Tool for Patients with Pulmonary Arterial Hypertension
PHORA:肺动脉高压患者的临床决策支持工具
- 批准号:
9207492 - 财政年份:2017
- 资助金额:
$ 65.64万 - 项目类别:
Salivary Gland-Based Gene Therapy for Pulmonary Arterial Hypertension
基于唾液腺的肺动脉高压基因治疗
- 批准号:
8608587 - 财政年份:2013
- 资助金额:
$ 65.64万 - 项目类别:
IGF::OT::IGF Vascular Interventions/Innovations and Therapeutic Advances (VITA): A Study to Explore the Feasibility of using Combined Modalities to Test the Safety of CaridMEMS Device in PAH Patients
IGF::OT::IGF 血管干预/创新和治疗进展 (VITA):一项探索使用组合方式测试 CaridMEMS 设备在 PAH 患者中安全性的可行性的研究
- 批准号:
8947688 - 财政年份:2013
- 资助金额:
$ 65.64万 - 项目类别:
Salivary Gland-Based Gene Therapy for Pulmonary Arterial Hypertension
基于唾液腺的肺动脉高压基因治疗
- 批准号:
8445512 - 财政年份:2013
- 资助金额:
$ 65.64万 - 项目类别:
Pharmacogenomics in Pulmonary Arterial Hypertension
肺动脉高压的药物基因组学
- 批准号:
6966645 - 财政年份:2005
- 资助金额:
$ 65.64万 - 项目类别:
Pharmacogenomics in Pulmonary Arterial Hypertension
肺动脉高压的药物基因组学
- 批准号:
7118932 - 财政年份:2005
- 资助金额:
$ 65.64万 - 项目类别:
Pharmacogenomics in Pulmonary Arterial Hypertension
肺动脉高压的药物基因组学
- 批准号:
7465528 - 财政年份:2005
- 资助金额:
$ 65.64万 - 项目类别:
Pharmacogenomics in Pulmonary Arterial Hypertension
肺动脉高压的药物基因组学
- 批准号:
7252454 - 财政年份:2005
- 资助金额:
$ 65.64万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 65.64万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 65.64万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 65.64万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 65.64万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 65.64万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 65.64万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 65.64万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 65.64万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 65.64万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 65.64万 - 项目类别:
Research Grant